The Cardio IQ™ Direct LDL Test directly measures low-density lipoprotein cholesterol (LDL-C), the “bad cholesterol” linked to atherosclerosis and cardiovascular disease. Unlike calculated LDL, this test provides accurate results even with high triglycerides or non-fasting samples. Doctors use it to assess heart disease risk, guide therapy decisions, and monitor patients on lipid-lowering treatments to improve cardiovascular health outcomes.

The Advanced Cholesterol Lab Panel is an extensive set of tests designed to provide a detailed profile of a person's cholesterol and lipoprotein levels. Unlike basic cholesterol tests, this advanced panel includes measurements of specific types of cholesterol particles, ratios, and additional markers that offer a deeper insight into cardiovascular health. The tests in this panel include Apolipoprotein B, Cholesterol/HDLC Ratio, Total Cholesterol, HDL Cholesterol, LDL Cholesterol, LDL/HDL Ratio, Non-HDL Cholesterol, Triglycerides, Lipoprotein (a), HDL Large, LDL Medium, LDL Particle Number, LDL Pattern, LDL Peak Size, and LDL Small.

The NMR Lipoprotein Fractionation Test uses nuclear magnetic resonance to measure particle size and concentration of LDL, HDL, and VLDL cholesterol. Unlike a standard lipid panel, it provides detailed information on lipoprotein subfractions linked to cardiovascular risk. Doctors use this test to assess heart disease risk, guide cholesterol management, and monitor therapy effectiveness. It offers deeper insight into lipid metabolism and cardiovascular health.

The Cardio IQ™ Lipoprotein Fractionation Ion Mobility Test separates and measures lipoprotein particles by size and concentration using ion mobility technology. It provides a detailed profile of LDL, HDL, and other subclasses, offering a clearer assessment of cardiovascular risk than standard cholesterol testing.

Advanced cardiovascular panel measuring lipoprotein particle size and number, ApoB, Lipoprotein (a), hs-CRP, homocysteine, TSH, and a full lipid profile. Designed to refine atherosclerosis and coronary heart disease risk assessment beyond standard cholesterol testing, this panel supports deeper evaluation of arterial health, inflammation, and metabolic influences.

The Advanced TRL Phenotyping & Therapy Readiness Panel provides a detailed evaluation of triglyceride-rich lipoproteins, atherogenic particle burden, inflammation, and metabolic readiness. By combining advanced lipid, NMR particle analysis, ApoB, ApoC-III, insulin, liver function, and OmegaCheck testing, this blood panel delivers deep insight into remnant-driven cardiovascular risk beyond standard cholesterol testing.

 The Advanced Cholesterol Panel + Inflammatory Marker Panel is a sophisticated diagnostic tool designed to evaluate cardiovascular risk from multiple dimensions. This comprehensive assessment combines traditional lipid profiling with advanced biomarkers for atherosclerosis and inflammation, offering a deep dive into an individual’s lipid metabolism and cardiovascular health. The integration of these tests provides a nuanced view of both the quantity and quality of cholesterol particles and the presence of inflammation, which is a known risk factor for cardiovascular diseases.

The Healthy Blood Vessels - The Advanced Lipid Panel with Lp(a) is a comprehensive diagnostic tool designed to provide an in-depth assessment of cardiovascular risk based on lipid profile and specific markers associated with cardiovascular diseases. This panel includes tests for Apolipoprotein B, Lipoprotein (a), a traditional Lipid Panel with Ratios, and Lipoprotein Fractionation Ion Mobility. By evaluating these specific biomarkers, the panel offers a nuanced view of lipid metabolism and its implications for heart health, beyond what a standard lipid panel provides.

An advanced women’s cardiovascular risk panel evaluating lipid particles, ApoA1/ApoB ratio, Lipoprotein (a), inflammation (hs-CRP), homocysteine, fibrinogen, galectin-3, insulin resistance, thyroid function, kidney health, leptin, adiponectin, vitamin D, ferritin, and more. Designed to provide a comprehensive cardiometabolic profile beyond standard cholesterol testing.

The Cardio IQ™ Advanced Lipid Panel Test provides a detailed assessment of cardiovascular risk by measuring total cholesterol, HDL, LDL, triglycerides, ApoB, Lipoprotein (a), and non-HDL cholesterol. It also analyzes particle number, size, and patterns of LDL and HDL, offering deeper insights into lipid metabolism and heart disease risk beyond standard cholesterol testing.

An extensive women’s cardiometabolic master panel combining advanced lipid particle testing, ApoA1/ApoB ratio, Lipoprotein (a), oxidized LDL, LP-PLA2, hs-CRP, cardiac biomarkers, thyroid antibodies, insulin resistance markers, kidney function, oxidative stress testing, and more. Designed to provide a comprehensive, multi-system evaluation of heart and metabolic health.

 The CVD-3 High Cholesterol Testing panel is a thorough diagnostic tool aimed at evaluating cardiovascular health by examining a broad spectrum of lipid profiles, inflammatory markers, and other specific tests related to heart disease risk. This panel includes Apolipoprotein A1, Apolipoprotein B, Direct LDL, hs-CRP, a Lipid Panel with Ratios, Lipoprotein (A), Cardio IQ™ Lipoprotein Fractionation, Ion Mobility, LP PLA2 Activity, and VLDL Cholesterol. It's designed for a comprehensive assessment of cardiovascular risk factors, particularly for individuals at high risk or with existing cardiovascular conditions.

The Cardio IQ™ Cholesterol Total Test measures the total amount of cholesterol in the blood, including HDL and LDL, to assess cardiovascular risk. High cholesterol is linked to heart disease, stroke, and atherosclerosis. Doctors use this test as part of advanced lipid testing to evaluate overall heart health, guide lifestyle or treatment decisions, and monitor patients with risk factors such as diabetes, obesity, or hypertension.

The Cardio IQ™ Triglycerides Test measures triglyceride levels in the blood, an important marker of lipid metabolism and cardiovascular health. Elevated triglycerides are linked to increased risk of heart disease, pancreatitis, and metabolic syndrome. Physicians use this test to assess risk factors, monitor therapy response, and guide lifestyle or treatment decisions, often as part of a broader lipid or heart health evaluation.